Form 4: Accolade Inc. President Robert Cavanaugh Reports Stock Transactions

Sentiment:

SEC Form 4


Robert N. Cavanaugh, President of Accolade, Inc., reports the conversion of Restricted Stock Units (RSUs) and subsequent sale of shares to cover tax obligations.

Summary

  • On May 10, 2024, Robert N. Cavanaugh, President of Accolade, Inc., converted 710 Restricted Stock Units (RSUs) into common stock.
  • Following the conversion, Mr. Cavanaugh directly held 173,177 shares of common stock.
  • On May 13, 2024, Mr. Cavanaugh sold 206 shares at a price of $7.444 per share to cover tax withholding obligations related to the vesting of RSUs.
  • After the sale, Mr. Cavanaugh directly held 172,971 shares of common stock.
  • The RSUs vest in installments, starting one year after June 10, 2022, and continuing monthly until fully vested on the three-year anniversary.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in insider ownership.

Key Dates

DateDescription
June 10, 2022June 2022 RSU Vesting Commencement Date
May 10, 2024Conversion of Restricted Stock Units to Common Stock
May 13, 2024Sale of Common Stock to cover tax obligations
May 14, 2024Date of Form 4 signature

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.